AnaptysBio
ANAB
ANAB
129 hedge funds and large institutions have $2.13B invested in AnaptysBio in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+8
Holders Change %
+6.61%
% of All Funds
2.8%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
22
Increased
53
Reduced
29
Closed
13
Calls
$16.5M
Puts
$13.3M
Net Calls
+$3.2M
Net Calls Change
-$721K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$27.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.6M |
| 3 |
Millennium Management
New York
|
+$14.2M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$9.71M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.21M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$38.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$13.6M |
| 3 |
Morgan Stanley
New York
|
-$10.5M |
| 4 |
AG
Artal Group
Luxembourg
|
-$9.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.98M |
